Binance Labs has made its first foray into the Decentralized Science (DeSci) sector with an investment in BIO Protocol (BIO), a pioneering platform aimed at transforming early-stage scientific research financing and commercialization through blockchain technology.
BIO Protocol is likened to a Y Combinator for on-chain science, bringing together scientists, patients, and investors globally to fund, develop, and co-own innovative drugs and therapeutics via Biotech Decentralized Autonomous Organizations (BioDAOs).
The protocol seeks to address critical limitations in traditional scientific funding models, particularly those impacting research in rare diseases, longevity, and emerging health challenges.
BIO’s network currently includes seven BioDAOs, each focused on areas such as cryopreservation, women’s health, and the use of psychedelics for mental health treatments.
The upcoming cohort of projects is set to expand this network further with initiatives aimed at finding treatments for Long COVID, rare diseases, and the development of quantum microscopes for studying quantum biological phenomena.
The recent investment from Binance Labs will support the growth of the BioDAO ecosystem by providing seed funding for new BioDAOs and enhancing the network of service providers that deliver community and tokenomics support.
This effort aligns with BIO’s mission to establish an autonomous infrastructure for scientific funding and innovation, powered by advancements in AI, drug design, and open-source computational biology.
The partnership marks a significant milestone for Binance Labs, known for its commitment to investing in projects that drive impactful technology within the Web3 ecosystem.
Established in 2018, Binance Labs has backed over 250 projects across 25 countries, focusing on innovation that demonstrates strong product-market fit and sustainable business models, irrespective of market cycles.
BIO Protocol’s efforts aim to revolutionize how scientific research is funded by shifting away from traditional grant-dependent models.
The protocol provides a framework that allows scientists to dedicate more time to research rather than securing funding. By leveraging the global liquidity provided by Binance Labs, BIO Protocol plans to scale patient-driven research initiatives from Boston to Singapore to Bangalore.
BIO Protocol was founded by members of VitaDAO and seeks to empower global scientific communities to fund and co-own breakthroughs in biomedical fields, including longevity and rare diseases. Notable supporters of BIO Protocol include Zee Prime Capital, Boost VC, and Northpond Ventures.
